AIDS 2022: Pearls to Optimize our Canadian AIDS Strategies!
Dr. Jean-Pierre Routy | December 1, 2022 12-1pm ET
Learning objectives: (1) Describe HIV/AIDS burden in Canada. (2) Compare Canadian strategies to optimal World strategies toward WHO elimination strategy. (3) Propose major changes to our Canadian AIDS strategy following AIDS 2022. (4) Adopt new objectives to assure we are reaching WHO objectives of AIDS elimination.
ABOUT THE SPEAKER: Dr. Jean-Pierre Routy, MD FRCPC
Clinical Director of the Chronic Viral Illness Service, Louis Lowenstein Chair in Hematology & Oncology
Local Co-Chair 24th International AIDS Conference – July 29 – August 2, 2022 Montreal
Dr. Jean-Pierre Routy is a Professor of Medicine, Clinical Director of the Chronic Viral Illness Service, Louis Lowenstein Chair in Hematology & Oncology. Dr. Routy has dedicated the last two decades bringing science and treatment innovation to help combat the health challenges of AIDS and cancer care. His fight against AIDS-related malignancies has led him to obtain in 2012 the McGill University Louis Lowenstein Chair in Hematology & Oncology. As an FRQS Clinician-Scientist, he was able to implement the Montreal Primary HIV-Infection cohort, which generated important findings in HIV pathogenesis and drug resistance. His achievements have led Dr. Routy to become the National Co-Director of the Immunotherapy and Vaccine Core at the Canadian Institutes of Health Research for HIV Trials Network. Since 2011, he co-chairs the Eradication Clinical Working Group for the International AIDS Society.
ABOUT THE MODERATOR: Dr. Bradley Stoner
Professor and Head, Department of Public Health Sciences; Professor, Department of Medicine
Queen’s University
Dr. Bradley P. Stoner received the MA degree in Anthropology from McGill University, followed by MD and PhD degrees at Indiana University. He then completed internal medicine residency training at Duke University Medical Center, and subsequently undertook infectious disease fellowship training at the University of Washington in Seattle. Prior to his appointment at Queen’s, Dr. Stoner was an Associate Professor of Anthropology and Medicine at Washington University in St. Louis, Missouri, where he specialized in the clinical care and epidemiological analysis of sexually transmitted infections. He is past-president of the American Sexually Transmitted Diseases Association (ASTDA), and is board-certified in infectious diseases and internal medicine.
